Case Number | Sample Size | Outcome | Reference |
1 | 4 | This study showed that hUC-MSC transplantation is a safe and an effective treatment for ITP, with an annual optimal period of transplantation. | [32] |
2 | 2 | Both paediatric patients, one diagnosed with AML with MDS-related changes and monosomy 7 and the other with MDS with monosomy 7, were treated successfully following UCB-HSCT transplantation. | [34] |
3 | 1 | Following the transplantation of hUC-MSCs, the IPF patient showed improvements in term of quality of life, physical performance and respiratory parameters (lung function, 6MWD and CT fibrosis score). | [35] |
4 | 34 | The patients-suffering from moderate to severe AD-responded positively to hUCB-MSCs transplantation, showing a dose-dependent therapeutic effect. | [36] |
5 | 14 | The test group showed a significantly higher mean root coverage compared to the control group. | [40] |
6 | 1 | 8 months post-treatments, the patient had a complete resolution of all symptoms, showed no complications related to the HU-MSCs treatment and all medications were discontinued. | [41] |